Test Price
2,800 AED✅ Home Collection Available
WNT5A Gene (Robinow Syndrome, Autosomal Dominant Type 1) Genetic Test in UAE | 2800 AED
Executive Summary & Core Metrics
High-precision genetic diagnosis for autosomal dominant Robinow syndrome via next-generation sequencing, compliant with UAE regulatory standards.
- Clinical Accuracy: 99.9% diagnostic sensitivity for coding exons and canonical splice sites via ISO 9001:2015 Accredited Processing.
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (daily, 8 AM – 11 PM).
- Clinical Guidance: Telephonic Post-Test Clinical Interpretation support by DHA-licensed genetic specialists.
- Insurance & Billing: Direct Electronic Billing Verification via WhatsApp at +971 54 548 8731.
Test Overview & Methodology
This targeted Next Generation Sequencing (NGS) assay analyzes the entire coding region of the WNT5A gene, identifying pathogenic variants responsible for autosomal dominant Robinow syndrome (ADRS) with >99.9% analytical sensitivity. Results guide precise clinical management, genetic counseling, and family risk assessment.
| Parameter | Our WNT5A NGS Test | Closest Alternative (Sanger Sequencing) |
|---|---|---|
| Precision | 99.9% detection of SNVs, indels in coding exons ±10 bp | ~95% due to limited coverage of GC-rich regions |
| Method | High-depth NGS with orthogonal confirmation | Capillary electrophoresis – slower, single variant focus |
| Turnaround Time | 3–4 Weeks (expedited options available) | 4–6 Weeks, often batched |
Physician Insight & Safety Protocols
Advisory Notice
⚠ Do not discontinue or modify any prescribed medication without consulting your treating physician.
Exclusion Criteria & Emergency Red Flags
- Receipt of allogeneic blood transfusion, bone marrow/stem cell transplant, or leukoreduced products within the last 4 weeks (risk of donor DNA contamination).
- Uncertain paternity or undisclosed donor conception must be declared for accurate interpretation.
- Patients under 18 require documented parental/guardian consent in compliance with Federal Decree-Law No. 4 of 2016 on Medical Liability.
- ER Red Flags: Seek immediate emergency care if the child develops acute respiratory distress, cyanosis, severe feeding difficulties, or sudden neurological deterioration—these may require urgent intervention beyond the test scope.
Patient FAQ & Clinical Guidance
1. How accurate is the WNT5A genetic test for confirming Robinow syndrome diagnosis?
The test delivers >99.9% analytical sensitivity and specificity for pathogenic single nucleotide and indel variants, confirming diagnosis with near-perfect reliability.
2. What information must I bring for the pre-test genetic counseling session?
You will need a detailed three-generation family pedigree, clinical photographs of affected members, and any previous ultrasound or dysmorphology reports to maximize test interpretation accuracy.
3. Can the test be performed on a newborn or infant under UAE law?
Yes, with mandatory prior genetic counseling, signed parental consent as per Federal Decree-Law No. 4 of 2016 on Medical Liability, and a clinical indication; the blood sample can be safely collected via heel prick or venipuncture.
UAE Regulatory & Data Privacy Adherence
Data Protection & Health Information Governance
All genetic data processing complies with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Patient information is encrypted, accessed only by authorized personnel, and used solely for diagnostic purposes with explicit consent. The laboratory holds DHA Facility License No. 1143 and adheres to international standards for genetic testing confidentiality.
Clinical & Logistical Metadata
| Test Name | WNT5A Gene (Robinow Syndrome, Autosomal Dominant Type 1) Genetic Test |
| Price (AED) | 2,800 |
| Turnaround Time | 3–4 Weeks (expedited options available) |
| Sample Type / Matrix | Whole Blood (EDTA) – 5 mL |
| Methodology Used | Next Generation Sequencing (NGS) of coding exons and splice sites |
| ICD-10-CM Code | Q87.8 (Other congenital malformation syndromes, not elsewhere classified) |
| LOINC Code | 52050-5 (WNT5A gene mutation analysis in blood) |
| DHA Facility License & Laboratory Address | DHA License No: 1143 Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE Corporate Lab: DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians